Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0SB6Y
|
|||
Former ID |
DNC013560
|
|||
Drug Name |
D-211A
|
|||
Synonyms |
D-211A; CHEMBL263636; SCHEMBL10291414
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C29H33FN2O
|
|||
Canonical SMILES |
C1CC(N2CCN(C1C2)CCC(C3=CC=C(C=C3)F)O)C(C4=CC=CC=C4)C5=CC=CC=C5
|
|||
InChI |
1S/C29H33FN2O/c30-25-13-11-22(12-14-25)28(33)17-18-31-19-20-32-21-26(31)15-16-27(32)29(23-7-3-1-4-8-23)24-9-5-2-6-10-24/h1-14,26-29,33H,15-21H2/t26-,27-,28+/m0/s1
|
|||
InChIKey |
GAKAYJNKCDLKCE-HZFUHODCSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Further structural optimization of cis-(6-benzhydryl-piperidin-3-yl)-benzylamine and 1,4-diazabicyclo[3.3.1]nonane derivatives by introducing an ex... Bioorg Med Chem. 2008 Mar 15;16(6):2769-78. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.